NasdaqCM - Delayed Quote USD
Aligos Therapeutics, Inc. (ALGS)
7.71
-0.32
(-3.99%)
At close: June 13 at 4:00:02 PM EDT
7.98
+0.27
+(3.50%)
After hours: June 13 at 7:25:04 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-78,906
-80,743
-78,997
-79,389
-115,662
Investing Cash Flow
26,296
-18,279
44,981
-26,293
3,022
Financing Cash Flow
102,116
355
88,328
164
78,677
End Cash Position
73,873
37,107
135,774
81,462
186,980
Income Tax Paid Supplemental Data
--
--
--
0
0
Interest Paid Supplemental Data
--
--
--
0
0
Capital Expenditure
-104
-130
-19
-943
-892
Issuance of Capital Stock
101,742
0
17,443
0
78,584
Repayment of Debt
-64
-83
-96
-61
-79
Free Cash Flow
-79,010
-80,873
-79,016
-80,332
-116,554
12/31/2021 - 10/16/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CLDI Calidi Biotherapeutics, Inc.
0.3450
+0.47%
ASMB Assembly Biosciences, Inc.
16.85
-1.46%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.7263
-6.88%
BIVI BioVie Inc.
1.1400
-4.20%
PMVP PMV Pharmaceuticals, Inc.
1.0800
-0.92%
SGMT Sagimet Biosciences Inc.
8.27
-3.95%
IKNA Ikena Oncology, Inc.
1.3500
-1.46%
KZR Kezar Life Sciences, Inc.
4.5900
-4.18%
VTYX Ventyx Biosciences, Inc.
2.5600
+2.81%
BOLT Bolt Biotherapeutics, Inc.
6.10
-2.09%